Zobrazeno 1 - 10
of 423
pro vyhledávání: '"Pieter E Postmus"'
Autor:
Jincey D. Sriram, Irma van de Beek, Paul C. Johannesma, Michiel H. van Werkum, Tijmen J. W. T. van der Wel, Elise M. Wessels, Hans J. J. P. Gille, Arjan C. Houweling, Pieter E. Postmus, Hans J. M. Smit
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Birt-Hogg-Dubé syndrome (BHD) is an inherited disease caused by pathogenic variants in the FLCN gene. One of the characteristics is the increased risk for spontaneous pneumothorax, likely due to the presence of pulmonary cysts ma
Externí odkaz:
https://doaj.org/article/f65c31c8c14841f3b507b58dca520cd2
Autor:
Liesbeth M. Hondelink, MD, Merel Jebbink, MD, Jan H. von der Thüsen, MD, PhD, Danielle Cohen, MD, PhD, Hendrikus J. Dubbink, PhD, Marthe S. Paats, MD, PhD, Anne-Marie C. Dingemans, MD, PhD, Adrianus J. de Langen, MD, PhD, Mirjam C. Boelens, PhD, Egbert F. Smit, MD, PhD, Pieter E. Postmus, MD, PhD, Tom van Wezel, PhD, Kim Monkhorst, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 12, Pp 100252- (2021)
Introduction: With the approval of first-line osimertinib treatment in stage IV EGFR-mutated NSCLC, detection of resistance mechanisms will become increasingly important—and complex. Clear guidelines for analyses of these resistance mechanisms are
Externí odkaz:
https://doaj.org/article/15653a46b49e44dca1398d582c62eabe
Autor:
Daniel Morgensztern, Manuel Cobo Dols, Santiago Ponce Aix, Pieter E. Postmus, Jaafar Bennouna, Jürgen R. Fischer, Oscar Juan-Vidal, David J. Stewart, Andrea Ardizzoni, Rafia Bhore, Marianne Wolfsteiner, Martin Reck, Denis Talbot, Ramaswamy Govindan, Teng Jin Ong
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Background: The standard therapy for advanced stage non-small cell lung cancer (NSCLC) with no actionable gene alterations is a platinum-based chemotherapy doublet and immune checkpoint blocker (ICB), either concurrently or sequentially, followed by
Externí odkaz:
https://doaj.org/article/559690e73ee44470a728f1e9dd145ed5
Autor:
Marloes A Smit, Mark WH Philipsen, Pieter E Postmus, Hein Putter, Rob AEM Tollenaar, Danielle Cohen, Wilma E Mesker
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100247- (2020)
Objectives: The tumor-stroma ratio (TSR) is based on the relative amount of stroma in the primary tumor and has proven to be an independent prognostic factor in various solid tumors. The prognosis of patients and adjuvant treatment decision making in
Externí odkaz:
https://doaj.org/article/31d903b64c484d2b88bfc184efc99696
Autor:
Paul C Johannesma, Irma van de Beek, Tijmen J W T van der Wel, Rinze Reinhard, Lawrence Rozendaal, Theo M Starink, Jan Hein T M van Waesberghe, Simon Horenblas, Hans J J P Gille, Marianne A Jonker, Hanne E J Meijers-Heijboer, Pieter E Postmus, Arjan C Houweling, Jeroen R A van Moorselaar
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0212952 (2019)
Birt-Hogg-Dubé syndrome is associated with an increased risk for renal cell carcinoma. Surveillance is recommended, but the optimal imaging method and screening interval remain to be defined. The main aim of our study was to evaluate the outcomes of
Externí odkaz:
https://doaj.org/article/e061467c213648bc94569e95baa4bfc1
Autor:
Tom G. Sutedja, Pieter E. Postmus, Jean LeRiche, Annette McWilliams, Katrien Grunberg, Adi F. Gazdar, Stephen Lam, Remco M. van den Berg, Pyng Lee
Supplementary Data from Color Fluorescence Ratio for Detection of Bronchial Dysplasia and Carcinoma In situ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9af75ca3264f2f558e06f93ad41bca
https://doi.org/10.1158/1078-0432.22440627.v1
https://doi.org/10.1158/1078-0432.22440627.v1
Autor:
Adriaan A. Lammertsma, Egbert F. Smit, Pieter E. Postmus, N. Harry Hendrikse, Albert D. Windhorst, Jonas Eriksson, Hugo B. Rutten, Emile F.I. Comans, Henri N. Greuter, Gerarda J.M. Herder, Walter J. Loos, Ron H.J. Mathijssen, Mark Lubberink, Astrid A.M. van der Veldt
PDF File - 77K, Supplementary data showing measurements in evaluable tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d9158d33cd2ed944aa82823bbcc4b18
https://doi.org/10.1158/1078-0432.22448435.v1
https://doi.org/10.1158/1078-0432.22448435.v1
Autor:
Adriaan A. Lammertsma, Egbert F. Smit, Pieter E. Postmus, N. Harry Hendrikse, Albert D. Windhorst, Jonas Eriksson, Hugo B. Rutten, Emile F.I. Comans, Henri N. Greuter, Gerarda J.M. Herder, Walter J. Loos, Ron H.J. Mathijssen, Mark Lubberink, Astrid A.M. van der Veldt
Purpose: Pharmacokinetics of docetaxel can be measured in vivo using positron emission tomography (PET) and a microdose of radiolabeled docetaxel ([11C]docetaxel). The objective of this study was to investigate whether a [11C]docetaxel PET microdosin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c422c5b4af07fd9d840db68cdb08de0
https://doi.org/10.1158/1078-0432.c.6521399.v1
https://doi.org/10.1158/1078-0432.c.6521399.v1
Autor:
N. Harry Hendrikse, Adriaan A. Lammertsma, Pieter E. Postmus, Daniëlle A. M. Heideman, Erik Thunnissen, Robert C. Schuit, Albert D. Windhorst, Maqsood Yaqub, Astrid A. M. van der Veldt, Mark Lubberink, Egbert F. Smit, Idris Bahce
PDF file - 46K, Metabolite analysis. Mean fractions of parent 11Cerlotinib, nonpolar metabolites and polar metabolites for groups 1 (filled symbols) and 2 (open symbols). Vertical bars indicate standard deviations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210a1ab24a5b653728dd6c8df2600365
https://doi.org/10.1158/1078-0432.22447226
https://doi.org/10.1158/1078-0432.22447226
Autor:
N. Harry Hendrikse, Adriaan A. Lammertsma, Pieter E. Postmus, Daniëlle A. M. Heideman, Erik Thunnissen, Robert C. Schuit, Albert D. Windhorst, Maqsood Yaqub, Astrid A. M. van der Veldt, Mark Lubberink, Egbert F. Smit, Idris Bahce
PDF file - 43K, Synthesis of 11Cerlotinib. Reaction conditions: 1.0 mg (2.6 μmole) of (1) 6-O-desmethyl-erlotinib, 11CCH3I, 250 μL of acetonitrile, 4.6 μmole of tetra-n-butylammonium hydroxide (2.0 μL of a 60% solution in water), 80 {degree sign}
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa9e50559092d1116cc136b3afc89462
https://doi.org/10.1158/1078-0432.22447229.v1
https://doi.org/10.1158/1078-0432.22447229.v1